Eric J. Hyllengren, SVP, CFO at Atara Biotherapeutics, Inc. (ATRA), sold 7,918 shares at $2.04 ($16K) on 2023-05-16, disclosed to the SEC on 2023-05-18.
Open-market sale of $16k ATRA by SVP, CFO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.04 | 1,719 | $4K | 21.7% |
| 2 | $2.04 | 6,199 | $13K | 78.3% |
| Total | $2.04 avg | 7,918 | $16K | 100% |
| Filing → |
| ATRA | SELL | 2024-08-20 | $7K | — | Filing → |
| ATRA | SELL | 2024-05-20 | $18K | — | Filing → |
| ATRA | SELL | 2024-03-06 | $5K | — | Filing → |